All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 1–9 of 9 drugs · filtered

TAKHZYRO (lanadelumab-flyo)

PLASMA KALLIKREIN INHIBITOR, RECOMBINANT MONOCLONAL ANTIBODY · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
DYAX CORP./SHIR

ORLADEYO (berotralstat hydrochloride)

PLASMA KALLIKREIN INHIBITOR, RECOMBINANT MONOCLONAL ANTIBODY · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
BIOCRYST PHARMA

TAKHZYRO (lanadelumab-flyo)

PLASMA KALLIKREIN INHIBITOR, RECOMBINANT MONOCLONAL ANTIBODY · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
TAKEDA PHARMACE

CINRYZE (C1 esterase inhibitor)

C1 ESTERASE INHIBITORS (PROPHYLAXIS) · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
MILLENNIUM PHAR

DAWNZERA (donidalorsen sodium)

PROPHYLAXIS HEREDITARY ANGIOEDEMA TREATMENT AGENTS · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
Ionis Pharmaceuticals, Inc.

CINRYZE (C1 esterase inhibitor)

C1 ESTERASE INHIBITORS (PROPHYLAXIS) · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
Takeda Pharmaceuticals America

TAKHZYRO (lanadelumab-flyo)

PLASMA KALLIKREIN INHIBITOR, RECOMBINANT MONOCLONAL ANTIBODY · PREVENTION OF ANGIOEDEMA ATTACKS IN PATIENT WITH HEREDITARY ANGIOEDEMA
Takeda Pharmaceuticals America